Financhill
Sell
26

MTD Quote, Financials, Valuation and Earnings

Last price:
$1,004.39
Seasonality move :
4.99%
Day range:
$962.54 - $996.88
52-week range:
$946.69 - $1,546.93
Dividend yield:
0%
P/E ratio:
23.94x
P/S ratio:
5.34x
P/B ratio:
--
Volume:
184.4K
Avg. volume:
197.6K
1-year change:
-18.37%
Market cap:
$20.3B
Revenue:
$3.9B
EPS (TTM):
$40.53

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MTD
Mettler-Toledo International
$875.8M $7.89 -5.42% -4.25% $1,289.13
CTSO
CytoSorbents
$9M -$0.07 13.09% -41.38% $5.00
DCTH
Delcath Systems
$16.8M $0.03 436.11% -93.78% $22.50
DGX
Quest Diagnostics
$2.6B $2.15 12.07% 25.69% $179.27
DHR
Danaher
$5.6B $1.64 1.02% 44.1% $255.02
WAT
Waters
$654.9M $2.23 2.93% 29.58% $390.59
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MTD
Mettler-Toledo International
$970.15 $1,289.13 $20.3B 23.94x $0.00 0% 5.34x
CTSO
CytoSorbents
$1.09 $5.00 $68.1M -- $0.00 0% 1.67x
DCTH
Delcath Systems
$11.34 $22.50 $378.8M -- $0.00 0% 8.96x
DGX
Quest Diagnostics
$161.86 $179.27 $18B 21.05x $0.80 1.88% 1.86x
DHR
Danaher
$184.96 $255.02 $132.2B 35.03x $0.32 0.61% 5.71x
WAT
Waters
$316.23 $390.59 $18.8B 29.53x $0.00 0% 6.37x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MTD
Mettler-Toledo International
106.72% 1.360 7.86% 0.64x
CTSO
CytoSorbents
51.51% 1.605 16.8% 1.46x
DCTH
Delcath Systems
-- 2.377 -- 10.46x
DGX
Quest Diagnostics
48.48% 0.464 38.46% 0.85x
DHR
Danaher
24.42% 0.391 9.7% 0.83x
WAT
Waters
47.08% 1.648 7.38% 1.34x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MTD
Mettler-Toledo International
$639.3M $333.7M 45.08% -- 31.81% $224.9M
CTSO
CytoSorbents
$4.5M -$4.4M -70.49% -103.21% -20.27% -$2.8M
DCTH
Delcath Systems
$13M $3M -97.08% -117.89% 68.93% -$1.2M
DGX
Quest Diagnostics
$858M $361M 7.24% 12.99% 14.16% $341M
DHR
Danaher
$3.9B $1.4B 5.65% 7.57% 21.05% $1.5B
WAT
Waters
$524.2M $292.3M 18.63% 43.99% 33.92% $188M

Mettler-Toledo International vs. Competitors

  • Which has Higher Returns MTD or CTSO?

    CytoSorbents has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -27.1%. Mettler-Toledo International's return on equity of -- beat CytoSorbents's return on equity of -103.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    CTSO
    CytoSorbents
    52.3% -$0.04 $26.8M
  • What do Analysts Say About MTD or CTSO?

    Mettler-Toledo International has a consensus price target of $1,289.13, signalling upside risk potential of 32.88%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 358.72%. Given that CytoSorbents has higher upside potential than Mettler-Toledo International, analysts believe CytoSorbents is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    3 9 1
    CTSO
    CytoSorbents
    1 1 0
  • Is MTD or CTSO More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison CytoSorbents has a beta of 1.167, suggesting its more volatile than the S&P 500 by 16.732%.

  • Which is a Better Dividend Stock MTD or CTSO?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or CTSO?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than CytoSorbents quarterly revenues of $8.6M. Mettler-Toledo International's net income of $252.3M is higher than CytoSorbents's net income of -$2.3M. Notably, Mettler-Toledo International's price-to-earnings ratio is 23.94x while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 5.34x versus 1.67x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    5.34x 23.94x $1B $252.3M
    CTSO
    CytoSorbents
    1.67x -- $8.6M -$2.3M
  • Which has Higher Returns MTD or DCTH?

    Delcath Systems has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -22.5%. Mettler-Toledo International's return on equity of -- beat Delcath Systems's return on equity of -117.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    DCTH
    Delcath Systems
    85.92% -$0.11 $68.7M
  • What do Analysts Say About MTD or DCTH?

    Mettler-Toledo International has a consensus price target of $1,289.13, signalling upside risk potential of 32.88%. On the other hand Delcath Systems has an analysts' consensus of $22.50 which suggests that it could grow by 98.41%. Given that Delcath Systems has higher upside potential than Mettler-Toledo International, analysts believe Delcath Systems is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    3 9 1
    DCTH
    Delcath Systems
    4 0 0
  • Is MTD or DCTH More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.853, suggesting its less volatile than the S&P 500 by 14.729%.

  • Which is a Better Dividend Stock MTD or DCTH?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or DCTH?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Delcath Systems quarterly revenues of $15.1M. Mettler-Toledo International's net income of $252.3M is higher than Delcath Systems's net income of -$3.4M. Notably, Mettler-Toledo International's price-to-earnings ratio is 23.94x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 5.34x versus 8.96x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    5.34x 23.94x $1B $252.3M
    DCTH
    Delcath Systems
    8.96x -- $15.1M -$3.4M
  • Which has Higher Returns MTD or DGX?

    Quest Diagnostics has a net margin of 24.14% compared to Mettler-Toledo International's net margin of 8.47%. Mettler-Toledo International's return on equity of -- beat Quest Diagnostics's return on equity of 12.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    DGX
    Quest Diagnostics
    32.74% $1.95 $13.3B
  • What do Analysts Say About MTD or DGX?

    Mettler-Toledo International has a consensus price target of $1,289.13, signalling upside risk potential of 32.88%. On the other hand Quest Diagnostics has an analysts' consensus of $179.27 which suggests that it could grow by 10.75%. Given that Mettler-Toledo International has higher upside potential than Quest Diagnostics, analysts believe Mettler-Toledo International is more attractive than Quest Diagnostics.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    3 9 1
    DGX
    Quest Diagnostics
    8 10 0
  • Is MTD or DGX More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.91%.

  • Which is a Better Dividend Stock MTD or DGX?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics offers a yield of 1.88% to investors and pays a quarterly dividend of $0.80 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Quest Diagnostics pays out 38% of its earnings as a dividend. Quest Diagnostics's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MTD or DGX?

    Mettler-Toledo International quarterly revenues are $1B, which are smaller than Quest Diagnostics quarterly revenues of $2.6B. Mettler-Toledo International's net income of $252.3M is higher than Quest Diagnostics's net income of $222M. Notably, Mettler-Toledo International's price-to-earnings ratio is 23.94x while Quest Diagnostics's PE ratio is 21.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 5.34x versus 1.86x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    5.34x 23.94x $1B $252.3M
    DGX
    Quest Diagnostics
    1.86x 21.05x $2.6B $222M
  • Which has Higher Returns MTD or DHR?

    Danaher has a net margin of 24.14% compared to Mettler-Toledo International's net margin of 16.61%. Mettler-Toledo International's return on equity of -- beat Danaher's return on equity of 7.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    DHR
    Danaher
    59.5% $1.49 $65.6B
  • What do Analysts Say About MTD or DHR?

    Mettler-Toledo International has a consensus price target of $1,289.13, signalling upside risk potential of 32.88%. On the other hand Danaher has an analysts' consensus of $255.02 which suggests that it could grow by 37.88%. Given that Danaher has higher upside potential than Mettler-Toledo International, analysts believe Danaher is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    3 9 1
    DHR
    Danaher
    19 4 0
  • Is MTD or DHR More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Danaher has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.413%.

  • Which is a Better Dividend Stock MTD or DHR?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Danaher offers a yield of 0.61% to investors and pays a quarterly dividend of $0.32 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MTD or DHR?

    Mettler-Toledo International quarterly revenues are $1B, which are smaller than Danaher quarterly revenues of $6.5B. Mettler-Toledo International's net income of $252.3M is lower than Danaher's net income of $1.1B. Notably, Mettler-Toledo International's price-to-earnings ratio is 23.94x while Danaher's PE ratio is 35.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 5.34x versus 5.71x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    5.34x 23.94x $1B $252.3M
    DHR
    Danaher
    5.71x 35.03x $6.5B $1.1B
  • Which has Higher Returns MTD or WAT?

    Waters has a net margin of 24.14% compared to Mettler-Toledo International's net margin of 26.52%. Mettler-Toledo International's return on equity of -- beat Waters's return on equity of 43.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    WAT
    Waters
    60.07% $3.88 $3.5B
  • What do Analysts Say About MTD or WAT?

    Mettler-Toledo International has a consensus price target of $1,289.13, signalling upside risk potential of 32.88%. On the other hand Waters has an analysts' consensus of $390.59 which suggests that it could grow by 23.51%. Given that Mettler-Toledo International has higher upside potential than Waters, analysts believe Mettler-Toledo International is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    3 9 1
    WAT
    Waters
    6 15 0
  • Is MTD or WAT More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Waters has a beta of 1.036, suggesting its more volatile than the S&P 500 by 3.583%.

  • Which is a Better Dividend Stock MTD or WAT?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waters offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Waters pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or WAT?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Waters quarterly revenues of $872.7M. Mettler-Toledo International's net income of $252.3M is higher than Waters's net income of $231.4M. Notably, Mettler-Toledo International's price-to-earnings ratio is 23.94x while Waters's PE ratio is 29.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 5.34x versus 6.37x for Waters. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    5.34x 23.94x $1B $252.3M
    WAT
    Waters
    6.37x 29.53x $872.7M $231.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Eli Lilly Stock Go By 2030?
How High Will Eli Lilly Stock Go By 2030?

The weight loss drugs market is heating up quickly and…

Is TSMC the Best Semiconductor Stock to Buy Now?
Is TSMC the Best Semiconductor Stock to Buy Now?

The new administration has launched a slew of tariffs, paused…

Rocket Lab Vs Intuitive Machines Stock
Rocket Lab Vs Intuitive Machines Stock

The commercialization of outer space is now in full swing,…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
40
Is NVDA Stock a Buy?

Market Cap: $2.4T
P/E Ratio: 33x

Alerts

Buy
58
AGX alert for Apr 22

Argan [AGX] is up 3.08% over the past day.

Sell
44
INOD alert for Apr 22

Innodata [INOD] is up 5.26% over the past day.

Sell
44
UHS alert for Apr 22

Universal Health Services [UHS] is up 2.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock